Long Wait Ahead For Novartis's Leqvio In US
German Launch In February, UK Maybe Q3
The timeline for a US resubmission of the closely watched PCSK9-targeting cholesterol treatment could be either Q2 or Q3 and approval will depend on whether the FDA needs to make a physical inspection of an Italian facility.
